Media Mentions & Press Releases

156K cancer patients could miss out on life-saving drugs every year in US and Europe Irish medtech company Diaceutics has announced research results showing that more than 156,000 cancer patients in the US and Europe could be missing out on targeted life-saving drugs every year due to suboptimal diagnostic testing – therefore potentially affecting their chances of survival.
May-2017 | Media Mentions
Diaceutics finds 156K cancer patients could miss out on life-saving drugs every year in US and Europe May-2017 | Press Releases
Personalized Medicine (PM) Connective Announces Achievement of Several Milestones May-2017 | Press Releases
Diaceutics signs multi-million-euro partnership with BioReference Laboratories to improve patient outcomes Apr-2017 | Press Releases